Voya Investment Management LLC Cassava Sciences Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 13,262 shares of SAVA stock, worth $33,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,262

Previous 13,561 2.2%

Holding current value

$33,552

Previous $167,000 133.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $2,861 - $10,488	-299 Reduced 2.2%	13,262 $390,000
Q2 2024 Dec 03, 2024	BUY	$12.35 - $26.11 $3,692 - $7,806	299 Added 2.25%	13,561 $167,000
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $5,051 - $10,678	409 Added 3.11%	13,561 $167,000
Q1 2024 Dec 06, 2024	SELL	$18.44 - $26.41 $2,028 - $2,905	-110 Reduced 0.83%	13,152 $266,000
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $48,312 - $69,194	-2,620 Reduced 16.61%	13,152 $266,000
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $3,261 - $7,768	-258 Reduced 1.61%	15,772 $355,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $4,076 - $6,203	245 Added 1.55%	16,030 $266,000
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $24,137 - $31,169	1,118 Added 7.62%	15,785 $387,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $4,480 - $6,960	-191 Reduced 1.29%	14,667 $353,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $6,221 - $19,453	381 Added 2.63%	14,858 $621,000
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $10,280 - $22,966	-597 Reduced 3.96%	14,477 $407,000
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $8,052 - $13,103	247 Added 1.67%	15,074 $560,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $1,029 - $2,545	28 Added 0.19%	14,827 $648,000
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $11,910 - $38,560	-285 Reduced 1.89%	14,799 $919,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $27,456 - $76,620	854 Added 6.0%	15,084 $1.29 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $5,672 - $70,360	800 Added 5.96%	14,230 $640,000
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $91,189 - $164,517	13,430 New	13,430 $92,000
Q3 2020 Nov 16, 2020	SELL	$2.86 - $11.51 $37,365 - $150,378	-13,065 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $26,652 - $125,946	13,065 New	13,065 $40,000

Others Institutions Holding SAVA

# of Institutions

196

Shares Held

13.8M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Cassava Sciences Inc Transaction History